Human-Relevant Models​ and Spatial Profiling​ Solutions

Embarking on the journey of establishing, expanding and sustaining a program that utilizes 2D and 3D human-relevant models for drug discovery and development is no easy feat. Where do you start? How do you unravel the answers to your critical research questions? These are the pressing challenges our customers confront daily. Frequent obstacles include the need for automation and standardization, expertise gaps, inadequate mechanisms for drug response reporting and restricted access to real-time data analysis.​

We recognize that cultivating and analyzing microphysiological systems—such as organoids and spheroids—demands a well-defined strategic approach. With our advanced, purpose-built cell culture platforms, cutting-edge analytical instruments, spatial profiling technologies and sophisticated enterprise-level AI-driven data analysis software, the Life Sciences companies of Danaher stand ready to partner with you on this transformative journey. Together, we can overcome barriers and unlock the full potential of your research in drug discovery and development.

Automation & Standardization

Automation and standardization enhance drug discovery by improving reproducibility, efficiency, and reliability in human-relevant models like organoids and 3D cultures.

Learn More

Expertise

We specialize in cultivating and analyzing microphysiological systems, like organoids, to enhance research integrity and accuracy for better decision-making.

Learn More

Mechanisms to Report on Drug Response

Understanding drug response is crucial to all drug discovery and development programs, as miscalculations can lead to failed clinical trials and patient harm.

Learn More

Decision Making with Real-Time Data Analysis

Quick access to insights demands tools for real-time analysis, data consolidation, reduced analysis time, and faster insights delivery.

Learn More